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Abstract
Tularemia is a zoonotic disease caused by Francisella tularensis. The microorganism is transmitted to humans by 
contact with, or ingestion of, infected animal tissues, by insect bites, consumption of contaminated food or water, 
or from inhalation of aerolized bacteria. In this report we describe a case of tularemia presenting with multiple
cervical lymphadenitis in Asturias (Spain). Final diagnosis was established based on a serological test. The patient 
was successfully managed with surgery and streptomycin for 2 weeks. The ulceroglandular form of tularemia 
should be considered in the differential diagnosis of cervical lymphadenitis, particularly in those not respond-
ing to penicillin treatment. To our knowledge, this is the first case described in Asturias, a north coast county of 
Spain.
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Introduction
Tularemia is a zoonotic infection caused by Francisella 
tularensis (F. tularensis), a non-capsulated, Gram-neg-
ative coccobacillus. Two main types of F. tularensis 
have been described, type A and type B, which have 
differences in their epidemiology and virulence (1). F. 
tularensis biovar type A has the highest mortality rate 
in humans and is predominantly seen in North Ameri-
ca; type B, a less virulent biovar, is widely distributed 
throughout the Northern Hemisphere. In Spain, this is 
a rare illness with sporadic reports. The first tularae-
mia outbreak in northwestern Spain (Castilla-León) oc-
curred in 1998 with 585 cases (2), and there was another 
in 2004 with 13 cases (3). Between 2000 and 2003, sev-
en cases were reported in that region. The last outbreak 
was reported in 2007 with 362 cases confirmed in the 
same zone of the country (3).
We report one case of ulceroglandular tularemia in As-
turias, north coaster county of Spain. The disease had 
not been previously reported in this region. 
Case Reports
A 77-year-old woman arrived at the department of oral 
and maxillofacial surgery of the University Central Hos-
pital (Asturias, Spain) in August 2007 with a 2-months 
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history of fever and left cervical mass. The patient did 
not refer arthralgia or joint swelling. There was no his-
tory of recent travel or exposure to ill people. She had 
received non-specific treatment (oral amoxicillin/clavu-
lanate) for 2 weeks without improvement. 
In the physical examination she had fixed left cervical 
mass, of 8 cm in diameter. It was more painful on palpa-
tion and exhibited increased local surface temperature 
and redness. Other physical examination signs were nor-
mal. No cutaneous or intraoral lesions were observed. 
A detailed examination of the oral cavity did not iden-
tify a cause. Orthopantomography did not reveal radi-
olucencies or dental pathology. 
In the laboratory investigations, the leukocyte count was 
9800 (63% neutrophills, 34% lymphocytes, 3% mono-
cytes), haemoglobin 12.3 g/dl, platelet count 352,000/
mm3 and the erythrocyte sedimentation rate was 53 
mm/h. Serum electrolytes and liver and kidney func-
tion tests were normal. 
A fine-needle aspiration biopsy of the cervical mass 
revealed lymphadenitis with a focal necrotic area. Cy-
tologic evaluation showed no evidence of cancer. Com-
puted tomography revealed multiple left cervical and 
supraclavicular lymphadenopathies with necrotic areas 
(Fig.1). 
The patient was taken to the operating room in Octo-
ber 2007 and the abscessed cervical and supraclavicu-
lar mass was drained and removed. Intraoperative bi-
opsy was consistent with granulomatous lymphadenitis. 
Stained cultures were obtained to look for tuberculosis 
and aerobic and anaerobic organisms. 
The pathologists entertained the possibility of tubercu-
losis and recommended additional test to search for a 
bacteriological source. Confirmatory diagnosis of ul-
ceroglandular tularaemia was made by haemaglutinin 
titers. Serologic tests later showed that the patient had 
a Francisella tularensis infection, and antibody levels 
were 4096 mg/UI. Antimicrobial therapy (streptomycin 
1 g every 12 hours IM) was given for 14 days and the pa-
tient recovered completely. During the patient s´ recovery, 
she related that feeds rabbits in her country house. These 
animals were the most likely vector for the infection. 
Discussion
The first report of F. tularensis infection was reported in 
1911 by McCoy in Tulare County, California (4). F. tula-
rensis is a short rod-shaped or coccoid, faintly staining, 
strictly aerobic Gram-negative bacterium which com-
prises two predominant subspecies, F. tularensis spp. 
tularensis (Jellison type A) and F. tularensis spp. hol-
arctica (Jellison type B). F. tularensis type A is isolated 
in North America while F. tularensis type B is spread 
more widely over the Northern hemisphere and is the 
sole subspecies isolated in European countries (5). 
A variety of small mammals (as rodents and lago-
morphs) are natural reservoirs of F. tularensis, which 
they acquire through bites by ticks, flies and mosquitoes 
or by contact with contaminated soil or water. The mi-
croorganism is transmitted to humans by direct contact 
with infected animals, by insect bites, by inhalation or 
by contact with contaminated meat or water (6).
The incubation period averages 3 to 5 days, but ranges 
from fewer than 1 to 21 days (1,7). After this period, 
symptoms consist of fever, chills, headache, cough, and 
myalgias. Ulceroglandular tularaemia is most frequent-
ly caused by vector-borne transmission, in the USA and 
Central European regions by ticks and in Northern Eu-
rope by mosquitoes. Patients with ulceroglandular tu-
laremia have a local cutaneous papule which develops 
at the time of onset of general symptoms (1). Within a 
few days, the papule may become pustular and ulcerate 
and after this, regional lymph node enlargement is no-
ticed by the patient. Enlarged lymph nodes, especially 
in the cervical and periauricular area, are seen in ap-
proximately 85% of patients and may be the only clini-
cal sign in nearly 50% of infected persons (8). 
Respiratory tularaemia is contracted by inhalation of 
aerosolised F. tularensis. Compared with the ulcerog-
landular form, outbreaks of respiratory tularaemia oc-
cur infrequently, especially in Europe (1). 
Fig. 1. Computed tomography image showing 
left cervical and supraclavicular lymphadenopa-
thies with necrotic areas.
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As the culture and isolation of the bacterium is difficult, 
the microbiological diagnosis of tularaemia relies main-
ly on serology (9). Tube agglutination and microagglu-
tination are usually preferred for diagnosis, although 
during the last decades, have been replaced by enzyme-
linked immunosorbent assay (ELISA). Results become 
positive 10-14 days after the onset of the disease (6). In 
the pathological examination of the tularaemia lymph 
nodules, lesions are characterized by the presence of 
histiocytes, macrophages, lymphocytes and giant cells 
in addition to necrosis areas. Results in routine labora-
tory tests are non-specific (10). 
The drug of first choice for the treatment of all forms 
of tularemia is streptomycin, although gentamicin is an 
acceptable substitute. Betalactams, macrolides, lincosa-
mides, and trimoxazole are not reliable for treatment of 
tularaemia. Ciprofloxaxin has also been demonstrated 
to be effective in vitro and in infected animals. The 
therapy must be given for 7-14 days (1,10). 
In comparison with the Nordic countries, the incidence 
is generally lower in central and southern Europe. In 
Spain, tularaemia in humans was first reported in 1998, 
when 585 cases occurred in Castilla-León, a big inner 
county on north-western (2). In 2004 were detected 13 
cases. Recently, in 2007 have been reported 362 cases 
in the same region (3). In the 1998 outbreak, the mech-
anism of transmission was by contact, while in 2007 
inhalation has been more frequent. To our knowledge, 
there has not been reported any case of tularaemia pre-
viously in Asturias, a small coaster county on north 
Spain. 
Conclusion
This case of ulceroglandular tularemia demonstrate that 
while rare in a nonendemic area, the disease must be 
considered in patients with lymphadenitis with necrotic 
areas who fail to improve with antibiotic therapy. Con-
tact with infected animals could guide the diagnosis 
that must be confirmed with serologic test or cultures. 
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